Stay updated on Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.

Latest updates to the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page
- Check6 days agoChange DetectedA site-wide banner announces NIH website transition updates and notes that “Super Intelligence” is replacing “Artificial Intelligence” in some federal agency content.SummaryDifference1%

- Check13 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoChange DetectedThe site revision label changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the expected study record content with an access-denied screen. The header and footer remain, but the study details are not accessible.SummaryDifference16%

- Check62 days agoChange DetectedAdds 'Schizophrenia' and 'MedlinePlus Genetics' to the related topics. The revision tag updates from v3.6.5 to v3.6.6, indicating a version change.SummaryDifference0.1%

- Check76 days agoChange DetectedSchizophrenia and MedlinePlus Genetics entries were removed from the MedlinePlus related topics on the page. This shortens the list of contextual topic links presented to users without altering core study information.SummaryDifference0.1%

Stay in the know with updates to Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.